Take Back Tomorrow HD

Take Back Tomorrow HD Fighting to raise awareness about a new treatment for Huntingtons Disease

This is why we fight! Together for access to treatments!
05/15/2026

This is why we fight! Together for access to treatments!

05/14/2026

NIAGARA FALLS LIGHTING FOR HD TONIGHT!

Don’t miss the iconic Niagara Falls lighting up in blue for HD and purple for Juvenile HD tonight from 10:00-10:15 P.M.

Visit the falls, invite some friends, snap a few photos, and help spark meaningful conversations about HD in your community.

Can’t make it in person? Watch the livestream here: https://www.earthcam.com/canada/niagarafalls/ 💙💜

What People Often Get Wrong About Huntington’s DiseaseHuntington’s disease is one of those conditions many people have h...
05/03/2026

What People Often Get Wrong About Huntington’s Disease

Huntington’s disease is one of those conditions many people have heard of, but few truly understand. Too often, it gets reduced to “a movement disorder” or confused with other neurological diseases. In reality, Huntington’s affects movement, thinking, mood, behavior, and families across generations.

One common misconception is that Huntington’s disease only causes involuntary movements. While uncontrolled movements can be part of it, the disease can also bring changes in memory, decision-making, depression, anxiety, irritability, and personality. For many families, the emotional and cognitive symptoms can be just as difficult as the physical ones.

Another misconception is that people with Huntington’s are “acting out” or choosing their behavior. They are not. Huntington’s causes progressive changes in the brain, which can affect impulse control, communication, emotions, and judgment. Compassion matters because what looks like stubbornness, anger, or withdrawal may actually be part of the disease.

Some people also think Huntington’s only affects older adults. Symptoms most often appear between ages 30 and 50, but they can begin earlier or later, and juvenile Huntington’s can affect children and teens.

There is also confusion about heredity. Huntington’s is genetic, and each child of a parent with Huntington’s has a 50% chance of inheriting the gene expansion that causes the disease. That means Huntington’s does not affect just one person. It affects entire families who may be living with symptoms, caregiving responsibilities, genetic testing decisions, grief, fear, and uncertainty.

And perhaps the biggest misconception is that a diagnosis means a person’s life is over. Huntington’s is serious and currently has no cure, but people with Huntington’s still deserve dignity, connection, support, good care, and full recognition of their humanity. A diagnosis does not erase who someone is.

Awareness matters. The more we understand Huntington’s disease, the better we can support the people and families living with it.

If you know someone affected by Huntington’s, listen without judgment. Learn before assuming. Offer help without waiting to be asked. And most of all, remember that behind every diagnosis is a person, a family, and a story that deserves compassion.

Decoding Huntington’s: How AI is Transforming Diagnosis and TreatmentHuntington’s Disease (HD) has long been one of the ...
04/17/2026

Decoding Huntington’s: How AI is Transforming Diagnosis and Treatment

Huntington’s Disease (HD) has long been one of the most daunting challenges in neurology. As a hereditary disorder caused by a single genetic mutation, its progression affects motor control, cognition, and emotional stability. However, the landscape of research is shifting. By 2026, AI has moved from a theoretical promise to a practical engine for early detection and personalized care.

1. Precision Diagnosis: Beyond the Genetic Test

While a genetic test confirms the presence of the mutation, it cannot tell a patient exactly when symptoms will start. AI is filling this gap.

• Voice AI as a Screening Tool:

Sophisticated algorithms now analyze speech patterns and vocal tremors imperceptible to the human ear. This allows for detection in the "premanifest" stage—years before physical symptoms appear.

• AI-Enhanced Neuroimaging:

AI software is revolutionizing MRIs. By using Deep Learning, researchers can now automate brain analysis to detect microscopic reductions in brain structures long before they are visible to a human radiologist.

2. Accelerating Treatment and Drug Discovery

The "holy grail" of research is a treatment that lowers the levels of the toxic mutant huntingtin protein. AI is accelerating this quest:

• Genomic Language Models:

Researchers are using AI to understand why the age of onset varies so wildly between patients. By identifying "modifier genes," doctors can better predict a patient's specific disease trajectory.

• Drug Pipeline Optimization:

AI-assisted image analysis is now used to detect protein aggregates in brain tissue at a speed and scale previously impossible, helping move drugs through clinical trials faster.

3. Improving Quality of Life

AI isn't just about the lab; it’s about the living room. For patients currently managing the disease, AI-driven tools provide daily support:

• Motor Tracking: Wearable sensors combined with AI monitor involuntary movements in real-time, allowing doctors to adjust medications more precisely.

• Cognitive Support: AI-driven therapy apps use rhythmic cues to help patients maintain motor control and stability.

The Path Forward

As we move through 2026, the integration of AI into Huntington’s care represents a shift from reactive to predictive medicine. While a definitive cure remains the goal, AI is providing the clarity and speed necessary to transform Huntington’s from a mystery into a manageable condition.

By identifying the disease earlier, AI is offering the community something once in short supply: time.

Think Huntington's disease only affects older people? Wrong. Symptoms can start as early as your 20s or 30s. Another myt...
04/13/2026

Think Huntington's disease only affects older people? Wrong. Symptoms can start as early as your 20s or 30s.

Another myth: it's just about uncontrolled movements. Reality check - memory loss, personality changes, and difficulty making decisions often show up first.

And here's the big one people get wrong: "There's nothing you can do about it." While there's no cure yet, physical therapy, speech therapy, and medications can significantly improve quality of life and slow progression.

Stop spreading outdated info. Huntington's families deserve accurate facts, not fear-based myths that were debunked years ago.

Treatments are on the way. Life and death will come down to time—and money.There’s no approved treatment yet—but it’s cl...
04/06/2026

Treatments are on the way. Life and death will come down to time—and money.

There’s no approved treatment yet—but it’s close. And it won’t be cheap.

We can’t change the timeline.
But we can make sure cost isn’t the reason someone misses their chance.

We’re getting ready now.

Donate:
https://www.paypal.com/donate/?hosted_button_id=VFTBLEBWQ9BZ2⁠�

Clarity in clinical trial design matters—especially in Huntington’s Disease.When the FDA requires placebo controls, half...
04/06/2026

Clarity in clinical trial design matters—especially in Huntington’s Disease.
When the FDA requires placebo controls, half of participants receive no treatment. In a rapidly progressive disease like HD, that’s not neutral—it can mean patients decline so far during the trial that they no longer qualify for the real therapy later.
For those patients, participation isn’t just a risk—it can cost them their only window for treatment.
HD is already fatal. If validated external controls exist, why force patients into a system where they might miss their only chance at a life-extending therapy?
Given the choice, most would take their chances on the real drug—not a placebo.

While recent FDA guidance speaks to the agency’s support of innovative trial designs—including the use of external controls—the application of this flexibility appears to be inconsistent. One former regulator says the situation is more nuanced.

Huntington’s disease doesn’t wait.It doesn’t wait for the FDA to schedule another meeting. It doesn’t wait for a Phase I...
04/04/2026

Huntington’s disease doesn’t wait.

It doesn’t wait for the FDA to schedule another meeting. It doesn’t wait for a Phase III trial design debate. It doesn’t wait while bureaucrats argue over whether patients should undergo sham brain surgery just to prove what we already know — that AMT-130 works.

Every month of delay is a month someone’s mother forgets their name. A month a father can no longer hold a fork. A month a child watches their parent disappear in slow motion.

uniQure built a gene therapy that is showing real promise. The FDA initially agreed on a path forward — then reversed course in January 2026, demanding a sham-surgery-controlled trial. That means drilling into a patient’s skull and injecting nothing. For science.

We’re not asking for shortcuts. We’re asking for urgency. We’re asking the FDA to stop treating dying patients like an acceptable cost of caution.

If this makes you uncomfortable, good. Now imagine living it.

What Is Huntington’s Disease? The Science Behind the Illness That Steals Everything - Dustin Anderson, Director of Advoc...
03/18/2026

What Is Huntington’s Disease?

The Science Behind the Illness That Steals Everything - Dustin Anderson, Director of Advocacy, Take Back Tomorrow HD

Most people have never heard of Huntington’s disease. But for the families it touches, it is impossible to forget — and impossible to escape.

HD is a rare, fatal, inherited neurological disorder that causes the progressive breakdown of nerve cells in the brain. It affects movement, cognition, and behavior simultaneously — robbing people of their ability to walk, speak, swallow, think clearly, and regulate their emotions, all at once.

There is currently no cure, and no treatment that slows its progression.
But to truly understand why HD is so devastating, you have to start at the very beginning — inside your DNA.

The Genetic Culprit: A Repeated Mistake
Every human carries a gene called HTT on chromosome 4. This gene contains a sequence of three DNA letters — cytosine, adenine, and guanine (CAG) — that repeat in a row. In people without HD, this CAG sequence repeats approximately 10 to 35 times. That’s normal.

In people with Huntington’s disease, that CAG sequence repeats 36 times or more. And the longer the repeat, generally the earlier and more severe the disease.

This single mutation — an extra stutter in a three-letter sequence of your genetic code — is all it takes to set the entire process in motion.

What Goes Wrong in the Brain

The HTT gene is responsible for producing a protein called huntingtin. Scientists believe normal huntingtin plays important roles in brain development and function. But when the gene carries the expanded CAG repeat, it produces a mutant huntingtin protein — one that is misfolded, toxic, and relentless.

This mutant protein accumulates in neurons, particularly in a region of the brain called the striatum, which is responsible for coordinating movement, decision-making, and emotional regulation. Over time, it damages and kills these neurons. The brain, quite literally, begins to shrink.
As neurodegeneration spreads, it reaches the cortex — the outer layer of the brain responsible for memory, reasoning, and personality. That’s when families begin to notice changes in mood, impulse control, and cognitive function, sometimes years before any movement symptoms appear.

The Three Faces of HD
Huntington’s disease attacks on three fronts simultaneously:

🔹 Motor symptoms — Chorea (involuntary, dance-like movements), loss of balance and coordination, difficulty swallowing, and eventually the inability to walk or speak.

🔹 Cognitive symptoms — Slowed processing speed, difficulty with planning and organization, memory lapses, and progressive dementia.

🔹 Psychiatric symptoms — Depression, anxiety, irritability, obsessive-compulsive behaviors, apathy, and in some cases psychosis. These are often the first signs of the disease, appearing years before a diagnosis is made.

It’s 100% Hereditary — With 50/50 Odds

Huntington’s disease is autosomal dominant — meaning only one copy of the mutated gene is needed to cause the disease. If a parent carries the HD gene mutation, each child has a 50% chance of inheriting it.

There are no carriers. If you inherit the mutation, you will develop HD — barring some other cause of death first. This creates an agonizing reality for families: watching a parent deteriorate while knowing there is a coin-flip chance that you or your siblings carry the same fate in your own DNA.

Many at-risk individuals choose to live without knowing their genetic status. Others test early, seeking the certainty — however difficult — to plan their lives.

The Timeline of the Disease

HD typically presents in mid-life, most commonly between the ages of 30 and 50, though it can appear earlier (Juvenile HD) or later in life. Once symptoms begin, the disease progresses relentlessly over 10 to 25 years. There is no remission. There is no plateau.

The final stages of HD leave individuals unable to communicate, unable to move independently, and fully dependent on round-the-clock care. The most common causes of death are pneumonia (often from aspiration due to swallowing difficulties), falls, and heart disease.

Where Science Stands Today

The HD research landscape has evolved dramatically in recent years. Scientists now understand the molecular mechanics of the disease with remarkable clarity — which is both a source of hope and, at times, of heartbreak.

Gene-silencing approaches, including antisense oligonucleotides (ASOs) and RNA interference (RNAi), aim to reduce production of the mutant huntingtin protein before it can cause damage. One of the most promising frontiers is gene therapy — the possibility of a one-time treatment that could silence or correct the underlying genetic mutation at its source.

That work is ongoing. And for the families waiting, it cannot move fast enough.

Why This Matters

Approximately 30,000 Americans are currently living with symptomatic HD, and an estimated 200,000 more are at risk due to family history. Globally, that number reaches into the hundreds of thousands. These are parents. Children. Siblings. Spouses.

They are people who woke up one day to learn that the future they had imagined — raising their kids, growing old with their partner, simply being present — had been quietly stolen by a three-letter typo written into their DNA before they were born.

At Take Back Tomorrow HD, we believe that understanding the science is the first step toward demanding better — from researchers, from pharmaceutical companies, and from the regulators who hold the power to accelerate access to treatments that could change everything.
Because knowledge isn’t just power. In HD, knowledge is urgency.

💙 Share this post if you believe more people should understand Huntington’s disease. The more voices we have, the louder the call for action becomes.

BREAKING: Congress is coming for answers — and the HD community is at the center of it.Senator Ron Johnson (R-WI), Chair...
03/12/2026

BREAKING: Congress is coming for answers — and the HD community is at the center of it.

Senator Ron Johnson (R-WI), Chair of the Senate’s Permanent Subcommittee on Investigations, has officially launched a formal investigation into the FDA’s recent string of rejections for rare disease therapies — and AMT-130 is squarely in the spotlight.

You already know the story. uniQure’s Huntington’s disease gene therapy showed a 75% slowing of disease progression over three years. The FDA reversed course anyway — demanding a sham surgery–controlled Phase 3 trial in which patients would have holes drilled in their skulls just to serve as a placebo group.

Senator Johnson isn’t mincing words. He called it “bureaucratic idiocy” and asked plainly: “You’re expecting people to go through sham surgeries where they get holes drilled in their heads?”

We’ve been asking the same question for months.

Senator Johnson is now requesting the FDA’s internal denial letters, and he’s considering calling top FDA officials — including Commissioner Marty Makary — to testify before Congress.

This is exactly the kind of oversight the HD community has been fighting for. When science is ignored, when guidance gets reversed without explanation, and when patients with a fatal disease are told to wait years more — that’s not caution. That’s a system failing the people it was designed to protect.

We stand with every HD family who has been waiting, advocating, and refusing to give up. Congress is starting to listen.
📢 Share this post. Tag your representatives. Let them know the HD community is watching.

💙

Address

Lenexa, KS

Alerts

Be the first to know and let us send you an email when Take Back Tomorrow HD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Take Back Tomorrow HD:

Share